SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Avadel AVDL
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who started this subject12/6/2003 7:56:43 PM
From: Kal Perry   of 240
 
Compare Flamel to SuperGen.
SuperGen SUPG is a red-hot biotech whose cure for pancreatic cancer, orathecine, is awaiting FDA approval. The CEO was a top scientst for Bristol-Myer-Squibb and also helped found Amgen. SuperGen could be a major pharmaceutical player. Its stock price is around $11. Makes me think Flamel is just alittle too expensive in the upper-20s.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News